Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,255,434
-$3,157,562 QoQ
Shares Held
52,136
-66.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,188
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First National Trust Co holds $128,309,128 across 8 Drug Manufacturers - General names. PFE ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,798 | $36,940,047 | |
| 2 | JNJ |
Johnson & Johnson
|
125,659 | $31,913,616 | |
| 3 | MRK |
Merck & Co., Inc.
|
179,140 | $23,019,489 | |
| 4 | ABBV |
AbbVie Inc.
|
74,068 | $18,638,470 | |
| 5 | AMGN |
Amgen Inc
|
42,011 | $15,213,022 | |
| 6 | PFE |
Pfizer Inc
This page
|
52,136 | $1,255,434 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,277 | $1,110,740 | |
| 8 | NVS |
Novartis AG
|
1,393 | $218,310 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,255,434 | 52,136 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,412,996 | 157,158 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,046,822 | 162,523 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,176,579 | 163,916 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $4,018,725 | 165,789 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $4,183,278 | 165,086 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $4,720,058 | 177,914 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,201,060 | 76,056 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,255,215 | 80,601 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,405,258 | 86,676 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $2,878,884 | 99,996 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,452,366 | 104,081 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,147,737 | 113,079 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $4,844,918 | 118,748 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $6,275,515 | 122,473 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $5,366,857 | 122,643 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $6,450,515 | 123,031 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $6,445,312 | 124,499 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $7,500,117 | 127,013 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $5,068,856 | 117,853 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $4,773,721 | 121,903 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,821,560 | 133,082 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $6,142,447 | 166,869 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,626,581 | 180,561 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $5,949,475 | 181,941 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $5,948,010 | 182,231 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||